glp-1 news 2025 october 9 We prescribe GLP-1 meds in our bariatric clinic like GLP-1 trends 2025: real-world data,
Description
Confirmed ginger's role in supporting digestive comfort across multiple clinical contexts
Orlistat (Alli), Sibutramine (Meridia), and Rimonabant (Acomplia) emerged, but some were banned due to cardiovascular and mental health risks

These drugs significantly reduced rates of #coloncancer (16% fewer cases) and #rectalcancer (28% fewer cases), among others like post-menopausal #breastcancer, #endometrialcancer, and #pancreaticcancer

27, 2024 (HealthDay News) -- Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says

Start your weight loss journey today.

Despite the hype about weight loss drugs known as GLP-1s, serious questions have remained about their efficacy when patients wean off the drugs